3) The aim and hypotheses of this study
Wavelet method has been widely applied in analyzing noisy, transient and non-stationary signals. One advantage of wavelet analysis is the ability to perform local analysis and reveal signal features with desired temporal-frequency resolution. Using coherence threshold to ensure a reliable relationship between ABP and ICP, we hypothesize that this method would perform better in CA assessment than a simple time correlation approach (PRx).
Hypothesis I:
The wavelet method can be used to assess CA for TBI patients. Higher wavelet phase shift, which results in smaller cosine value of the phase shift (terms as wPRx) is related with worse cerebral autoregulation; while smaller wavelet phase shift, i.e. higher wPRx, is related with better cerebral autoregulation;
Hypothesis II: The wavelet method offers better performance than the widely used method, pressure reactivity index (PRx), in terms of lower variability and distinguishing patient outcome.
Hypothesis III: Estimations of optimal cerebral perfusion pressure (CPPopt) in TBI patients using wPRx results in more stable trend with less discontinuities than using PRx. In order to test the ability of wPRx to delineate the optimal cerebral perfusion pressure (CPPopt), the automatic curve fitting methodology described in detail by Aries et al was used to estimate CPPopt value based on both wPRx (CPPopt_wPRx) and PRx (CPPopt_PRx) for this cohort of TBI patients.
4) Methods and materials

TBI patients admitted in
The relationship between PRx and wPRx, the reliability and stability of the two parameters, the ability of PRx and wPRx of giving CPPopt recommendation will be studied. The relationship between PRx or wPRx with patient outcome will also be compared.
Research Main Result
The result of this study positively verified the hypotheses listed in the research plan:
Result I: There was a significantly positive relationship between PRx and wPRx (r = 0.73) Result II: wPRx was more stable in time (2-hour interval standard deviation of wPRx (0.19± 0.07) was smaller than that of PRx (0.30 ± 0.13, p<0.001)). wPRx was more reliable(ratio of betweenhour variance to total variance, wPRx 0.957± 0.0032 vs PRx and 0.949 ± 0.047 for PRx, p=0.002).
Moreover, wPRx performed better in distinguishing between mortality and survival (AUROC for wPRx was 0.73 vs 0.66 for PRx, p = 0.003).
Result III: CPPopt yield was significantly increased by using wPRx (CPPopt_PRx 53.2% ± 20% vs CPPopt_wPRx 59.6% ± 27%, p<0.001) and CPPopt_wPRx was more stable (within patient standard deviation 7.05 ± 3.78 vs 8.45 ± 2.90; p<0.001).
